| | RAD51L3-RFFL, RAD51D (T328I +2 more) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G325S +2 more) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (T201S +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51L3-RFFL, RAD51D (I311N +2 more) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +6 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (E307K +2 more) | Single nucleotide variant (missense variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (R188L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (R300Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (R300* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +4 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (L295V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (A293V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R290Q +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R275W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (W268* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (R266C +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G265R +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast and/or ovarian cancer +3 more | |
| | RAD51D, RAD51L3-RFFL (I251K +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (V247L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (R239W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R232* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +5 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (G106S +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (A210E +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | RAD51D, RAD51L3-RFFL (A210V +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S207L +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary breast ovarian cancer syndrome +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Deletion (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome | |
| | | Insertion (splice donor variant) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (A190T +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R186* +2 more) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (Q183* +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (R165W +2 more) | Single nucleotide variant (non-coding transcript variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | | Single nucleotide variant (intron variant) | not provided +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +4 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51L3-RFFL, RAD51D (Q148* +1 more) | Single nucleotide variant (nonsense +2 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (R145H +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (S144F +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +4 more | |
| | RAD51L3-RFFL, RAD51D (N138D +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (V132I +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (N131S +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (A122E +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (A122fs +1 more) | Deletion (frameshift variant +2 more) | Hereditary breast ovarian cancer syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51L3-RFFL, RAD51D (C119Y +1 more) | Single nucleotide variant (missense variant +2 more) | not specified +3 more | |
| | RAD51D, RAD51L3-RFFL (C119R +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary breast ovarian cancer syndrome +5 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (C117S +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | not provided +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Hereditary cancer-predisposing syndrome +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (Q115* +1 more) | Single nucleotide variant (nonsense +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (K113N +1 more) | Single nucleotide variant (missense variant +2 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +2 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51D, RAD51L3-RFFL (S111N +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (T103S +1 more) | Single nucleotide variant (missense variant +2 more) | Hereditary cancer-predisposing syndrome | |
| | RAD51D, RAD51L3-RFFL (K111fs +1 more) | Duplication (frameshift variant +2 more) | Hereditary cancer-predisposing syndrome +3 more | GPathogenic/Likely pathogenic |
| | RAD51D, RAD51L3-RFFL (D98fs) | Deletion (frameshift variant +1 more) | RAD51D-related disorder +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (D90G) | Single nucleotide variant (missense variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (intron variant) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | RAD51D, RAD51L3-RFFL (D70N) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (G68S) | Single nucleotide variant (missense variant +1 more) | not provided +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | |
| | RAD51D, RAD51L3-RFFL (V66M) | Single nucleotide variant (missense variant +1 more) | not provided +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +2 more | |
| | RAD51D, RAD51L3-RFFL (S62L) | Single nucleotide variant (missense variant +1 more) | not specified +4 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (R55Q) | Single nucleotide variant (missense variant +1 more) | not specified +4 more | |
| | RAD51D, RAD51L3-RFFL (A49V) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast and/or ovarian cancer +4 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | RAD51D, RAD51L3-RFFL (S46C) | Single nucleotide variant (missense variant +1 more) | not specified +5 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +1 more | |
| | RAD51D, RAD51L3-RFFL (L19P) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | RAD51D, RAD51L3-RFFL (Q18R) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +3 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (synonymous variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 4 +2 more | |
| | RAD51D, RAD51L3-RFFL (T13I) | Single nucleotide variant (missense variant +1 more) | not provided +2 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | not provided +3 more | |
| | | Single nucleotide variant (synonymous variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | RAD51L3-RFFL, RAD51D (C9S) | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +5 more | GConflicting classifications of pathogenicity |